GL
GSK plc
GLAXF · OTC
$23.51 -6.72% (-$1.70)
1M -6.67%
Market Cap £72.5B
P/E Ratio 16.70x
Div. Yield 3.66%
ROE 25.57%
Bulios Fair Price
$26.05
10.8% upside
Trenutna cena
$23.51
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GLAXF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
82 /100
Cheap P/E 16.70x
P/FCF 11.37x
EV/EBITDA 8.86x
Growth
35 /100
Stable EPS growth 27.58%
Book val. growth 15.61%
Rev. growth 3.66%
Profitability
89 /100
Strong Gross margin 73.35%
FCF margin 20.46%
Net margin 13.93%
Quality
72 /100
Excellent ROIC 11.55%
Asset turnover 0.51x
ROE 25.57%
Debt
64 /100
Moderate Debt/Equity 1.03x
Net debt/EBITDA 1.52x
Current ratio 0.82x
Stability
51 /100
Moderate Beta 0.30x
Profitable years 6
Rev. volatility 0.38%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GLAXF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Luke Victor Miels
Employees
66,841
Headquarters
London
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report